Notice: This company has been marked as potentially delisted and may not be actively trading. Ocuphire Pharma (OCUP) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Ocuphire Pharma (NASDAQ:OCUP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.70%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$80,260.00Number OfInsiders Selling(Last 12 Months)0 Get OCUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Ocuphire Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OCUP Insider Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Ocuphire Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/22/2024Ashwath JayagopalInsiderBuy3,500$1.76$6,160.00 3/21/2024Joseph K SchachleCOOBuy2,000$2.05$4,100.00 3/21/2024Nirav S JhaveriCFOBuy10,000$2.10$21,000.00 3/18/2024George MagrathCEOBuy25,000$1.96$49,000.00 (Data available from 1/1/2013 forward) OCUP Insider Trading Activity - Frequently Asked Questions Who is on Ocuphire Pharma's Insider Roster? The list of insiders at Ocuphire Pharma includes Ashwath Jayagopal, George Magrath, James S J Manuso, Joseph K Schachle, Mina Sooch, and Nirav S Jhaveri. Learn more on insiders at OCUP. What percentage of Ocuphire Pharma stock is owned by insiders? 8.70% of Ocuphire Pharma stock is owned by insiders. Learn more on OCUP's insider holdings. Which Ocuphire Pharma insiders have been buying company stock? The following insiders have purchased OCUP shares in the last 24 months: Ashwath Jayagopal ($6,160.00), George Magrath ($49,000.00), Joseph K Schachle ($4,100.00), and Nirav S Jhaveri ($21,000.00). How much insider buying is happening at Ocuphire Pharma? Insiders have purchased a total of 40,500 OCUP shares in the last 24 months for a total of $80,260.00 bought. Ocuphire Pharma Key ExecutivesMr. George Magrath M.B.A. (Age 40)M.D., M.S., CEO & Director Compensation: $625.07kMr. Bernhard Hoffmann M.B.A. (Age 68)Senior Vice President of Corporate Development & Secretary Compensation: $434.1kDr. Jay S. Pepose M.D. (Age 69)Ph.D., Chief Medical Advisor & Director Compensation: $392kMs. Amy Zaremba Rabourn C.P.A. (Age 43)MAcc, Senior Vice President of Finance Compensation: $434.1kMr. Nirav Suresh Jhaveri C.F.A. (Age 46)Chief Financial Officer Mr. Joseph K. Schachle MBA (Age 59)Chief Operating Officer Dr. Ashwath Jayagopal Ph.D. (Age 42)Chief Scientific & Development Officer Ms. Bindu ManneHead of Market Development & CommercializationMr. Erik SimsDirector & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies Cassava Sciences Insider Selling Allakos Insider Selling Alto Neuroscience Insider Selling MediciNova Insider Selling Regulus Therapeutics Insider Selling Applied Therapeutics Insider Selling Pyxis Oncology Insider Selling ALX Oncology Insider Selling Milestone Pharmaceuticals Insider Selling Immunic Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:OCUP) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocuphire Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
